updates on the use of gepants in migraine
Published 1 year ago • 343 plays • Length 5:51Download video MP4
Download video MP3
Similar videos
-
2:16
how to integrate gepants into migraine clinical care
-
5:33
real-world studies of cgrp monoclonal antibodies and gepants for migraine
-
0:47
the future of oral-cgrp drugs in migraine prevention
-
5:12
updates on the phase iii team study of cefaly for migraine treatment
-
1:10
emerging evidence on gepants and medication overuse headache
-
4:44
the updated guidelines for treating migraines with cgrp-targeted monoclonal antibodies
-
3:02
upcoming treatments for migraine: zavegepant, rimegepant and atogepant
-
1:26
update on ehf guideline for anti-cgrp antibodies for migraine prevention
-
4:05
for or against? anti-cgrp monoclonal antibodies as a first-line therapy for migraines
-
2:14
the future of migraine prevention with cgrp-targeted agents
-
27:45
simplifying new migraine treatments: gepants and ditans - spotlight on migraine s2:ep7
-
4:26
new treatments for migraine: who, what, and when?
-
1:56
navigating migraine treatment choices: monoclonal antibodies vs gepants
-
22:45
cgrp & gepants: what we know and what to expect
-
46:18
acute treatment of migraine with gepants: when you need to act fast
-
12:05
lessons on the side effects of cgrp antibodies in migraine
-
1:40
cgrp mabs have changed migraine treatment approaches
-
2:05
ahs highlights: atogepant and zavegepant for migraine treatment
-
2:45
discovering the power of gepants for migraines: nurtec and ubrelvy